119
Participants
Start Date
April 4, 2016
Primary Completion Date
June 26, 2017
Study Completion Date
September 13, 2017
SOF/VEL
400/100 mg FDC tablet administered orally once daily
Krasnoyarsk Regional Center of AIDS Prevention, Krasnoyarsk
Central Research Institute of Epidemiology, Moscow
Central Scientific-Research Institute of Epidemiology, Moscow
City Clinical Hospital # 24, Moscow
First Moscow Medical University I.M.Sechenov., Moscow
First Moscow State Medical University I.M. Sechenov, Moscow
"Limited Liability Company Clinic Tour", Moscow
Scientific Research Institute of Nutrition, Moscow
Sklifosovsky Scientific Research Institution of Emergency Care, Moscow
Center for Prevention and Control of AIDS and Infectious Diseases, Saint Petersburg
Kirov Medical Military Academy, Saint Petersburg
North-Western State Medical University named after I.I. Mechnikov, Saint Petersburg
"LLC Medical Company Hepatolog", Samara
Sahlgrenska Universitetsjukhuset, Gothenburg
Karolinska University Hospital Huddinge, Stockholm
Lead Sponsor
Gilead Sciences
INDUSTRY